Valuation : Virbac

Market Cap 2.69B 3.13B 2.52B 2.31B 4.31B 295B 4.34B 29.85B 11.63B 151B 11.74B 11.48B 486B P/E 2026 *
15.8x
P/E 2027 * 14.3x
Enterprise Value 2.82B 3.27B 2.64B 2.42B 4.51B 309B 4.55B 31.26B 12.17B 158B 12.29B 12.02B 509B EV / Sales 2026 *
1.82x
EV / Sales 2027 * 1.68x
Free-Float
49.03%
Yield 2026 *
0.53%
Yield 2027 * 0.63%
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-.--% - - 3.13B
+0.16%+1.69%-49.95%-59.94% 31.48B
-1.05%-0.29%+40.75%+102.15% 12.33B
-0.48%-2.00%-16.30%+2.97% 3.83B
-0.47%-3.31%-1.83%+18.45% 3.13B
+0.08%-2.69%+47.02%+30.51% 2B
0.00%-3.49%+15.03%+4.59% 1.9B
-3.36%+6.13%+1.01%+187.27% 1.62B
-3.25%+2.43%-20.28%-9.25% 1.21B
-0.30%-2.60%-11.21%-42.18% 1.03B
Average -0.93%-1.11%+0.47%+26.06% 6.5B
Weighted average by Cap. -0.01%-1.75%-17.94%-4.08%

Financials

2026 *2027 *
Net sales 1.55B 1.8B 1.46B 1.33B 2.49B 170B 2.51B 17.22B 6.71B 87.08B 6.77B 6.62B 280B 1.65B 1.91B 1.55B 1.41B 2.64B 181B 2.66B 18.29B 7.12B 92.49B 7.19B 7.03B 298B
Net income 171M 199M 161M 147M 274M 18.8B 276M 1.9B 740M 9.61B 747M 731M 30.94B 190M 220M 178M 163M 304M 20.83B 306M 2.1B 819M 10.64B 827M 809M 34.28B
Net Debt 127M 147M 119M 109M 203M 13.93B 205M 1.41B 548M 7.12B 553M 541M 22.92B 75.16M 87.35M 70.53M 64.53M 120M 8.26B 121M 834M 325M 4.22B 328M 321M 13.59B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA